Brief: Elicera Therapeutics Appoints Johan Liwing As New CEO
18/08/2026 07:33
BRIEF-Elicera Therapeutics Appoints Johan Liwing As New CEO Aug 18 (Reuters) - Elicera Therapeutics AB ELIC.ST:
APPOINTS JOHAN LIWING AS NEW CEO EFFECTIVE SEPTEMBER 1, 2026
JAMAL EL-MOSLEH TO REMAIN EMPLOYED UNTIL OCTOBER 31 FOR CEO HANDOVER
Source text: ID:nWkr2BMwS
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application